NEWSLETTER

By clicking submit, you agree to share your email address with TFN to receive marketing, updates, and other emails from the site owner. Use the unsubscribe link in the emails to opt out at any time.

AI healthcare Jutro Medical extends Series A to €36M for clinic acquisitions

Jutro Medical team
Image credits: Jutro Medical

Warsaw’s primary care market grapples with outdated GP practices, retirement waves, endless paperwork, and limited access to quality care. Jutro Medical offers an AI-first rollup model, acquiring clinics and integrating them into a unified platform of EHR, workflows, and smart agents that handle administrative tasks, allowing physicians to focus on patients.

The outfit just raised a €24m Series A extension led by Warsaw Equity Group, with Vinci, naturalX Health Ventures, Fluent Ventures, Aternus, KAYA VC, and Inovo VC participating, plus debt from mBank and Orbit Capital, bringing the total Series A to €36m.

Meet  Europe’s AI-first primary care

Adam Janczewski founded Jutro Medical in 2020 after observing Poland’s clinic chaos firsthand, channelling his tech expertise into a mission to fuse online and offline care and leverage AI to reduce bureaucracy. Born of frustration with telemedicine’s limits and the retirement of GPs, Janczewski’s team built a four-year software foundation to scale.

The end goal is to redefine publicly funded primary care, where AI agents manage thousands of interactions monthly, enabling doctors to ditch desks for real medicine. Jutro’s EHR powers AI agents for virtual consults, prescriptions, labs, and sick notes, and hands off complex cases to the same doctor at one of its owned clinics for seamless continuity.

Other features include clinic integration, 4.94/5 visit ratings from 500k+ encounters, and an 86 NPS, with AI backing 1,500 doctor visits last month alone. Unlike Babylon Health, Kry, or eMedica, Jutro’s unified ops boost margins and quality for 120k patients, outpacing them by owning the whole stack.

What’s next?

Fresh cash fuels 20+ annual clinic buys in Poland this year, then Europe-wide rollouts targeting €1bn revenue while holding EBITDA near break-even on 270% YoY growth.

Total
0
Shares
Related Posts
Total
0
Share

Get daily funding news briefings in the tech world delivered right to your inbox.

Enter Your Email
join our newsletter. thank you
TFN Banner